Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates

被引：0
|
作者：
John, M. [1 ]
Violante, R. [2 ]
Deerochanawong, C. [3 ]
Vijapurkar, U. [4 ]
Canovatchel, W. [4 ]
Hamilton, G. [5 ]
机构：
[1] Hlth & Res Ctr, Trivandrum, Kerala, India
[2] Ctr Estudios Invest Metab & Cardiovasc SC, Tampico, Mexico
[3] Rajavithi Hosp, Bangkok, Thailand
[4] Janssen Res & Dev LLC, Raritan, NJ USA
[5] Janssen Cilag Ltd, High Wycombe, Bucks, England
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
756
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
    John, Mathew
    Cerdas, Sonia
    Violante, Rafael
    Deerochanawong, Chaicharn
    Hassanein, Mohamed
    Slee, April
    Canovatchel, William
    Hamilton, Gill
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (09) : 775 - 785
  • [2] EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM INDIA
    Kumar, K. M. Prasanna
    Mohan, V.
    Sethi, B.
    Gandhi, P.
    Bantwal, G.
    Xie, J.
    Meininger, G.
    Qiu, R.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S260 - S261
  • [3] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America
    Lavalle-Gonzalez, Fernando J.
    Eliaschewitz, Freddy G.
    Cerdas, Sonia
    Del Pilar Chacon, Maria
    Tong, Cindy
    Alba, Maria
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (03) : 427 - 439
  • [4] The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus
    Gavin, James R., III
    Davies, Melanie J.
    Davies, Michael
    Vijapurkar, Ujjwala
    Alba, Maria
    Meininger, Gary
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1693 - 1702
  • [5] Efficacy and safety of canagliflozin in older subjects with type 2 diabetes mellitus
    Sinclair, A.
    Bode, B.
    Harris, S.
    Vijapurkar, U.
    Gassmann-Mayer, C.
    Fung, A.
    Shaw, W.
    Usiskin, K.
    Desai, M.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 : S383 - S383
  • [6] Efficacy and safety of canagliflozin monotherapy: results from 2 studies in patients with type 2 diabetes mellitus
    Jodar, E.
    Rosenstock, J.
    Chuck, L.
    Gonzalez-Ortiz, M.
    Tong, C.
    Capuano, G.
    Alba, M.
    Qiu, R.
    [J]. DIABETOLOGIA, 2015, 58 : S350 - S351
  • [7] Safety assessment of canagliflozin for type 2 diabetes mellitus
    Fan, Guoxin
    Han, Ruoshuang
    Zhang, Yuxin
    Zhang, Zhiyin
    Liu, Yifan
    Wang, Dongdong
    He, Shisheng
    Chen, Zhengqi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2595 - 2612
  • [8] Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin
    Rodbard, H. W.
    Seufert, J.
    Aggarwal, N.
    Cao, A.
    Fung, A.
    Pfeifer, M.
    Alba, M.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 812 - 819
  • [9] EFFICACY AND SAFETY OF CANAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS OF DIFFERENT ETHNICITY
    Davidson, Jaime A.
    Aguilar, Richard
    Lavalle Gonzalez, Fernando J.
    Trujillo, Angelina
    Alba, Maria
    Vijapurkar, Ujjwala
    Meininger, Gary
    [J]. ETHNICITY & DISEASE, 2016, 26 (02) : 221 - 228
  • [10] Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Hiroaki Iijima
    Takayuki Kifuji
    Nobuko Maruyama
    Nobuya Inagaki
    [J]. Advances in Therapy, 2015, 32 : 768 - 782
12345